Function of contralateral testis after artificial unilateral cryptorchidism in dogs.
The effects of a cryptorchid testis on the contralateral testis were investigated after artificially producing unilateral cryptorchidism in 8 beagle dogs. Bilateral testicular biopsy and collection of spermatic vein blood and peripheral vein blood were performed at the time of the operation to produce the cryptorchidism and 52 weeks later. The testicular tissue was used for histological examination by light microscopy and measurement of the testicular transferrin (Tf) concentration by enzyme immunoassay. Plasma testosterone (T), estradiol-17 beta (E2), and luteinizing hormone (LH) levels were measured by radioimmunoassay. Semen was collected weekly and its quality was examined. No spermatogenesis was observed in the cryptorchid testes at 52 weeks after the operation, and the number of germ cells in the contralateral testes had decreased but the number of Sertoli cells did not change. The Tf concentration in both testes had also decreased. The mean total number of sperm between 48 and 52 weeks after the operation (194 x 10(6)) was less than half the number before the operation (510 x 10(6)). Mean spermatic vein plasma T levels (51 ng/ml) in the cryptorchid testes 52 weeks after the cryptorchid operation were significantly lower than before the operation (91 ng/ml; P < 0.05). By contrast, spermatic vein plasma E2 levels (80 pg/ml) were significantly higher than the values before the operation (51 pg/ml P < 0.05). The peripheral plasma LH levels decreased. These findings indicate that a large quantity of E2 secreted by the cryptorchid testis inhibits the endocrine and spermatogenic functions of the contralateral testis in the dog. In particular, it is assumed that dysfunction of the contralateral testis is associated with Sertoli cell dysfunction suggested by the low Tf concentration.
Kawakami
E
E
Department of Reproduction, Nippon Veterinary and Animal Science University, Tokyo, Japan.
Hori
T
T
Tsutsui
T
T
D000818:Animals; D001706:Biopsy / Q000662:veterinary; D003456:Cryptorchidism / Q000503:physiopathology / Q000662:veterinary*; D004283:Dog Diseases / Q000503:physiopathology*; D004285:Dogs; D004958:Estradiol / Q000097:blood; D007124:Immunoenzyme Techniques / Q000662:veterinary; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D010503:Periodic Acid-Schiff Reaction / Q000662:veterinary; D011863:Radioimmunoassay / Q000662:veterinary; D012661:Semen / Q000378:metabolism; D012708:Sertoli Cells / Q000166:cytology; D013076:Sperm Count / Q000662:veterinary; D013091:Spermatogenesis / Q000502:physiology; D013737:Testis / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D013739:Testosterone / Q000097:blood; D014168:Transferrin / Q000032:analysis*
D014168:Transferrin; D013739:Testosterone; D004958:Estradiol; D007986:Luteinizing Hormone